Thanks, Bryan, and good afternoon, everyone. Starting with net revenue. The key takeaway for the quarter is that we delivered year-over-year growth despite an uneven demand environment. Net sales increased 4%, supported by a 6% lift in shipments as several higher throughput programs ramped. As expected, that benefit came with a mix shift. Incremental pounds skewed toward lower priced, lower margin wins, which compressed spreads on a consolidated basis. Turning to the full year, net sales declined 7.2% and as a 17.7% contraction in demand more than offset 10.9% in pricing action. In that context, we remain disciplined on value and continue to sharpen mix and execution, positioning the book to participate as volumes normalize. From a profitability standpoint in the quarter, while mix in the broader cycle remained uneven, gross profit was essentially flat year-over-year, down less than $50,000, and gross margin declined by approximately 90 basis points. Holding margin movement to that level, given the spread compression and demand variability is a solid outcome. And it reinforces that we're scaling throughput without compromising the earnings profile we're building. Stepping back to the full year, gross profit increased by $6.5 million and gross margin expanded by nearly 1,000 basis points driven by a 2.5% improvement in material profit as our sourcing initiatives, product line management, and operating execution took hold across the portfolio. Moving to SG&A. Expenses were $6.5 million compared to $5.4 million in the prior year period. The year-over-year comparison is influenced by merit accrual reversals in the fourth quarter of 2024, along with an unfavorable impact from litigation settlement expenses in the current period. On a full year basis, SG&A was up $3.2 million, largely driven by $2.1 million related to legacy Munhall and Palmer activity that was reclassed SG&A in the second quarter as well as stock compensation and incentive payouts, partially offset by reductions in professional fees. Adjusted EBITDA for the quarter was a loss of $1.1 million, a decrease of roughly $600,000 year-over-year. Full year EBITDA was a loss of $570,000, an improvement of $4.1 million year-over-year. Turning to the balance sheet. We ended the quarter with $57.6 million of cash, no debt and $11.4 million of incremental availability under our revolver. We finished the year with significant liquidity and a clean balance sheet, which gives us flexibility and staying power as we move through this part of the cycle. And with the cash conversion cycle down to 61 days, we're demonstrating tighter working capital discipline, building confidence that the business is getting more resilient even as demand softens. With that, I'll turn it back to the operator for questions.